Premaitha talks of 'strong' momentum following patent dispute resolution
25th Oct 2018 10:23
(Sharecast News) - Investors in molecular diagnostics company Premaitha Health were told on Thursday how the group's positive momentum had continued into the second half of its financial year.
Read morePremaitha revenues soar in first half
12th Oct 2018 09:11
(Sharecast News) - Premaitha Health revenues soared in the first half of its trading year and that good momentum has continued into the second half.
Read morePremaitha inks partnership agreement with mystery Taiwanese outfit
4th Oct 2018 12:50
(Sharecast News) - Molecular diagnostics outfit Premaitha has inked a new partnership agreement with an unnamed Taiwanese research organisation to deliver its next-generation sequencing testing in oncology.
Read morePremaitha appoints former ERBA Diagnostics CEO to board
20th Sep 2018 12:56
(Sharecast News) - Molecular diagnostics group Premaitha Health on Thursday appointed Hayden Jeffreys to the board as group commercial director upon completion of directorate appointment due diligence.
Read morePremaitha rockets by almost 50% after legal dispute settled
19th Sep 2018 16:33
(Sharecast News) - Molecular diagnostics outfit Premaitha Health saw its shares rocket after it entered into a legal settlement and a licence-and-supply partnership agreement with Illumina on Wednesday.
Read morePremaitha Health raisis £1.49m in share issue
15th Feb 2017 12:44
(ShareCast News) - Developer of a CE-marked non-invasive prenatal screening system, Premaitha Health, announced on Wednesday that it has agreed to issue to Harwood Capital 17 million new ordinary shares of 0.1p, subject to admission to AIM, raising £1.49m at a price of 8.75p. The AIM-traded firm sai
Read morePremaitha partners with major European diagnostics services group
13th Feb 2017 13:04
(ShareCast News) - Shares in Premaitha Health are up more than 4% on news it has partnered with a major European diagnostics services group to implement the IONA test in at least two laboratories. The four-year Master Procurement Agreement (MPA) was to install the IONA test in at least two of the cu
Read morePremaitha Health builds customer base in Southern Europe
7th Feb 2017 15:38
(ShareCast News) - Non-invasive prenatal screening system developer Premaitha Health announced a number of new customers through its distribution network in Southern Europe on Tuesday. The AIM-traded company confirmed its Italian distributor won a public hospital tender to implement the first public
Read morePremaitha Health to buy Taiwan's Yourgene Biosciences
21st Dec 2016 07:44
(ShareCast News) - Premaitha Health, a maker of non-invasive prenatal screening system, is to buy Taiwan's Yourgene Biosciences in a bid to expand the company in Asia. The acquisition of the Yourgene Biosciences, which distributes non-invasive prenatal screening systems, is subject to shareholder ap
Read morePremaitha Health expands pre-natal test in Thailand
21st Nov 2016 07:53
(ShareCast News) - Premaitha Health has agreed to offer its IONA non-invasive pre-natal screening test to a medical centre in Bangkok. The company's Thai subsidiary Geneplus will supply the neonatal test to the Centre for Medical Genomics at the Ramathibodi Hospital in Mahidol University, which has
Read morePremaitha welcomes decision to allow non-invasive prenatal tests on NHS
31st Oct 2016 11:32
(ShareCast News) - AIM-listed molecular diagnostics company Premaitha Health, a developer of a prenatal screening system, said on Friday it welcomed the decision by the Department of Health to make non-invasive prenatal tests routinely available on the NHS to high risk pregnant women. With the avail
Read morePremaitha Health welcomes NHS roll-out of NIPT to high-risk women
31st Oct 2016 10:50
(ShareCast News) - Premaitha Health welcomes the UK Department of Health's decision to make non-invasive prenatal tests (NIPT) routinely available on the NHS to high-risk pregnant women across the UK. The UK-based molecular diagnostics company said it expected NIPT to be rolled out across the NHS to
Read morePremaitha Health patent dispute reaches new level
22nd Apr 2016 12:18
(ShareCast News) - Non-invasive prenatal screening system developer Premaitha Health saw one if its patent disputes reach a new level early on Friday, as its competitor Illumina initiated infringement proceedings against Genoma - one of Premaitha's customers - in Switzerland. The AIM-traded firm sai
Read moreMonday broker round-up
21st Mar 2016 18:26
(ShareCast News) - Gulf Keystone: Canaccord downgrades to sell with a target price of 14p. B&M European: UBS reiterates buy, 350p target. Ascential: Goldman Sachs reiterates buy with a target price of 278p and Exane BNP Paribas stays at neutral with a target price of 250p. Premaitha Health: Panmur
Read morePremaitha propels prenatal test into Indian market
3rd Feb 2016 08:33
(ShareCast News) - Premaitha Health was propelling its IONA prenatal testing product into one of the world's largest markets on Wednesday, announcing its partnership with Visional Medical. The AIM-traded medical technology firm described Visional as a new organisation based in the UK and India, with
Read more